Male Infertility and Assisted Reproductive Technologies Research Biobank
Launched by REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY · Mar 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on male infertility and aims to create a special collection, called a biobank, of biological samples from men. These samples, which may include testicular tissue, sperm, and semen, will be used to help doctors understand and treat infertility issues, especially for patients undergoing treatments like IVF (in-vitro fertilization) or IUI (intrauterine insemination).
To participate, men who are providing these types of samples for clinical use or storage might be eligible. However, samples that are kept in quarantine due to infectious diseases cannot be included. If you join this trial, you will be contributing to important research that could improve fertility treatments for many men in the future. The study is currently recruiting participants, so if you meet the criteria, this could be a valuable opportunity to help others while learning more about your own health.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males providing testicular tissue, sperm, semen samples, discarded sperm preps for IUI/IVF/ICSI or the sperm recipient for those utilizing donor sperm, for cryopreservation at the respective site(s) for either clinical use or preservation
- Exclusion Criteria:
- • Samples that are quarantined or in isolation dewars for infectious diseases
About Reproductive Medicine Associates Of New Jersey
Reproductive Medicine Associates of New Jersey (RMANJ) is a leading fertility clinic dedicated to advancing reproductive health through innovative clinical practices and cutting-edge research. With a team of highly skilled specialists, RMANJ offers comprehensive services in assisted reproductive technology, including in vitro fertilization (IVF), egg freezing, and fertility preservation. The organization is committed to providing personalized care and leveraging the latest scientific advancements to optimize patient outcomes. Through its robust clinical trial initiatives, RMANJ aims to contribute to the ongoing evolution of reproductive medicine, fostering new therapies and improving access to effective fertility treatments for individuals and couples facing reproductive challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basking Ridge, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported